Imatinib mesylate (GleevecTM) reduces phlebotomy requirements in polycythemia vera

• 23 May 2003
• journal article
• Published by Springer Nature in Leukemia
• Vol. 17  (6) , 1186-1187
• https://doi.org/10.1038/sj.leu.2402938

Abstract

Keywords

• ONCOLOGY
• THERAPY
• STEM CELLS
• APOPTOSIS
• HEMOPOIESIS
• FUSION GENES
• HAEMATOLOGY
• IMMUNOLOGY